Full-Time
Posted on 7/29/2025
Remote mental health tracking platform
No salary listed
Philadelphia, PA, USA
In Person
NeuroFlow provides a healthcare technology platform that remotely tracks and manages mental health, helping practices, health systems, health plans, and government/military organizations integrate behavioral health into patient care. Its platform supports collaborative, measurement-based care at scale by delivering personalized, evidence-based tools and resources, enabling remote engagement to manage costs and adjust treatment plans through coordinated care. Revenue comes from subscription fees for the platform, which thousands of healthcare professionals use to improve patient wellness, readiness, and resiliency, and it also offers a secure mobile app for individuals to strengthen their mind-body connection.
Company Size
51-200
Company Stage
Grant
Total Funding
$56.3M
Headquarters
Philadelphia, Pennsylvania
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Flexible Work Hours
Unlimited Paid Time Off
Wellness Program
Mental Health Support
Health Insurance
Parental Leave
401(k) Retirement Plan
Gym Membership
Commuter Benefits
Journey Meditation, meditation services that are intended to strengthen focus and prioritize mental health for corporate employees, raised $7.6 million of venture funding from Gaingels and J4.Ventures.
ChristianaCare has teamed up with NeuroFlow to help support your mental health and emotional wellness during and after pregnancy.
What You Should Know: – NeuroFlow, a company focused on uncovering hidden behavioral health needs to enable more effective care, today published new research findings demonstrating how technology can significantly improve the ability to identify suicide risk, often among individuals who might otherwise go undiagnosed.– The studies highlight the potential for user-friendly digital tools and artificial intelligence (AI) to assess risk more efficiently, detect suicidal ideation sooner, and ultimately facilitate life-saving interventions.Suicide remains a critical public health crisis in the United States, with over 1.5 million people attempting suicide annually and approximately 49,000 lives lost each year. These staggering numbers, which continue to rise, carry devastating personal and societal impacts, contributing billions to healthcare costs. NeuroFlow emphasizes that effective prevention requires innovative approaches, as many individuals at risk are “hiding in plain sight.” Troublingly, over half of those who die by suicide have had contact with the healthcare system within 30 days prior to their death, indicating missed opportunities for intervention. Technology offers a path to identify these individuals sooner.Study 1: Everyday Digital Tracking Predicts Suicidal Ideation RiskThe first study, published in the Journal of Technology in Behavioral Science (JTIBS) and titled “Predicting Risk of Suicidal Ideation with Digital Ecological Momentary Assessment (EMA),” analyzed data from over 30,000 individuals using NeuroFlow’s digital platform. Users tracked daily metrics like mood, stress, sleep, and pain – tasks taking only a few seconds. The research found that these simple, self-reported measures accurately predicted the risk of suicidal ideation, with mood emerging as a particularly strong indicator
This acquisition follows NeuroFlow's 2024 purchase of Owl Health, which added advanced measurement-based care capabilities, and its recent partnership with Intermountain Health to incorporate predictive analytics for behavioral health risk management.
NeuroFlow, a behavioral health tech company, has acquired Quartet Health, a virtual mental health platform, to enhance its offerings. The acquisition, closing in January, will integrate Quartet's provider network and referral management with NeuroFlow's platform, benefiting customers like Independence Blue Cross and the federal government. This follows NeuroFlow's recent acquisition of Intermountain Health's analytics model and Owl in 2024, aiming to improve behavioral health care accessibility and effectiveness.